Trial · NCT01028911
Results by group241
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 241
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Clinically Significant Vital Sign Abnormalities | PF-03654746 and Donepezil | Supine SBP <90 mmHg | 0 | participants | |
| Number of Participants With Clinically Significant Vital Sign Abnormalities | Placebo and Donepezil | Supine SBP <90 mmHg | 0 | participants | |
| Number of Participants With Clinically Significant Vital Sign Abnormalities | PF-03654746 and Donepezil | Standing SBP <90 mmHg | 0 | participants | |
| Number of Participants With Clinically Significant Vital Sign Abnormalities | Placebo and Donepezil | Standing SBP <90 mmHg | 0 | participants | |
| Number of Participants With Clinically Significant Vital Sign Abnormalities | PF-03654746 and Donepezil | Supine DBP <50 mmHg | 0 | participants | |
| Number of Participants With Clinically Significant Vital Sign Abnormalities | Placebo and Donepezil | Supine DBP <50 mmHg | 0 | participants | |
| Number of Participants With Clinically Significant Vital Sign Abnormalities | PF-03654746 and Donepezil | Standing DBP <50 mmHg | 0 | participants | |
| Number of Participants With Clinically Significant Vital Sign Abnormalities | Placebo and Donepezil | Standing DBP <50 mmHg | 0 | participants | |
| Number of Participants With Clinically Significant Vital Sign Abnormalities | PF-03654746 and Donepezil | Supine pulse rate <40 bpm | 0 | participants | |
| Number of Participants With Clinically Significant Vital Sign Abnormalities | Placebo and Donepezil | Supine pulse rate <40 bpm | 0 | participants | |
| Number of Participants With Clinically Significant Vital Sign Abnormalities | PF-03654746 and Donepezil | Supine pulse rate >120 bpm | 0 | participants | |
| Number of Participants With Clinically Significant Vital Sign Abnormalities | Placebo and Donepezil | Supine pulse rate >120 bpm | 0 | participants | |
| Number of Participants With Clinically Significant Vital Sign Abnormalities | PF-03654746 and Donepezil | Standing pulse rate <40 bpm | 0 | participants | |
| Number of Participants With Clinically Significant Vital Sign Abnormalities | Placebo and Donepezil | Standing pulse rate <40 bpm | 0 | participants | |
| Number of Participants With Clinically Significant Vital Sign Abnormalities | PF-03654746 and Donepezil | Standing pulse rate >140 bpm | 0 | participants | |
| Number of Participants With Clinically Significant Vital Sign Abnormalities | Placebo and Donepezil | Standing pulse rate >140 bpm | 0 | participants | |
| Number of Participants With Clinically Significant Vital Sign Abnormalities | PF-03654746 and Donepezil | Su SBP: Maximum increase from baseline >=30 mmHg | 3 | participants | |
| Number of Participants With Clinically Significant Vital Sign Abnormalities | Placebo and Donepezil | Su SBP: Maximum increase from baseline >=30 mmHg | 0 | participants | |
| Number of Participants With Clinically Significant Vital Sign Abnormalities | PF-03654746 and Donepezil | St SBP: Maximum increase from baseline >=30 mmHg | 1 | participants | |
| Number of Participants With Clinically Significant Vital Sign Abnormalities | Placebo and Donepezil | St SBP: Maximum increase from baseline >=30 mmHg | 0 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01028911/results